BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31813023)

  • 61. Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.
    Maruo S; Wu Y; Ishikawa S; Kanda T; Iwakiri D; Takada K
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19500-5. PubMed ID: 17159137
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
    Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
    PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.
    Glaser LV; Rieger S; Thumann S; Beer S; Kuklik-Roos C; Martin DE; Maier KC; Harth-Hertle ML; Grüning B; Backofen R; Krebs S; Blum H; Zimmer R; Erhard F; Kempkes B
    PLoS Pathog; 2017 Oct; 13(10):e1006664. PubMed ID: 28968461
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An Epstein-Barr virus isolated from a lymphoblastoid cell line has a 16-kilobase-pair deletion which includes gp350 and the Epstein-Barr virus nuclear antigen 3A.
    Lee W; Hwang YH; Lee SK; Subramanian C; Robertson ES
    J Virol; 2001 Sep; 75(18):8556-68. PubMed ID: 11507201
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epstein-Barr virus-derived EBNA2 regulates STAT3 activation.
    Muromoto R; Ikeda O; Okabe K; Togi S; Kamitani S; Fujimuro M; Harada S; Oritani K; Matsuda T
    Biochem Biophys Res Commun; 2009 Jan; 378(3):439-43. PubMed ID: 19032945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth.
    Maruo S; Johannsen E; Illanes D; Cooper A; Kieff E
    J Virol; 2003 Oct; 77(19):10437-47. PubMed ID: 12970429
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
    PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epstein-Barr virus vectors for gene delivery to B lymphocytes.
    Robertson ES; Ooka T; Kieff ED
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11334-40. PubMed ID: 8876136
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanisms of B-Cell Oncogenesis Induced by Epstein-Barr Virus.
    Saha A; Robertson ES
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30971472
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R; Moses SC; Tan J; Kremmer E; Ling PD
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.
    Kanamori M; Watanabe S; Honma R; Kuroda M; Imai S; Takada K; Yamamoto N; Nishiyama Y; Kawaguchi Y
    J Virol; 2004 Apr; 78(8):3984-93. PubMed ID: 15047814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
    Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
    Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epstein-Barr virus (EBV) and human hematopoietic cell lines: a review.
    Tatsumi E
    Hum Cell; 1992 Mar; 5(1):79-86. PubMed ID: 1329932
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity.
    Rainio EM; Ahlfors H; Carter KL; Ruuska M; Matikainen S; Kieff E; Koskinen PJ
    Virology; 2005 Mar; 333(2):201-6. PubMed ID: 15721354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells.
    Yanagi Y; Okuno Y; Narita Y; Masud HMAA; Watanabe T; Sato Y; Kanda T; Kimura H; Murata T
    Virology; 2021 May; 557():44-54. PubMed ID: 33639481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.